Stock listing

NASDAQ:CELZ Creative Medical Technology Holdings, Inc. Stock

Home listing (NASDAQ) of Creative Medical Technology Holdings, Inc.

Follow Creative Medical Technology Holdings, Inc. into a list and get an email when it puts out news.

Share price · NASDAQ:CELZ

$0.403 USD -0.064 (-13.7%)

Close on Nov 20, 2026

Past year -85.3% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$0.400 – $0.433 USDNov 20, 2026
Volume
74,892 sharesNov 20, 2026
Market cap
$3.06M USDAt the close on Nov 20, 2026 · price × 7.60M shares outstanding
52-week range
$0.400 – $4.720 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$669,315 USDMedian day 118,800 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
Creative Medical Technology Holdings, Inc. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:CELZ · Home$0.403 USD-0.064 (-13.7%)74,892$0.433$0.433$0.400$0.466Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:CELZ · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$0.403-0.064-13.7%$0.433$0.433$0.40074,892
$0.466-0.010-2.2%$0.479$0.511$0.45040,099
$0.477-0.043-8.4%$0.523$0.523$0.46186,686
$0.520-0.008-1.5%$0.525$0.562$0.52088,880
$0.528-0.089-14.4%$0.615$0.623$0.528152,703
$0.617-0.013-2.1%$0.630$0.640$0.61356,277
$0.630+0.029+4.7%$0.600$0.649$0.60043,158
$0.601-0.011-1.8%$0.610$0.648$0.60034,645
$0.612-0.010-1.6%$0.613$0.635$0.600104,349
$0.622+0.016+2.7%$0.600$0.639$0.595101,317
$0.606-0.046-7.1%$0.700$0.700$0.590123,524
$0.652-0.022-3.2%$0.674$0.707$0.62258,795
$0.674+0.050+8.0%$0.645$0.674$0.630116,508
$0.624-0.031-4.8%$0.650$0.674$0.601224,680
$0.655-0.023-3.4%$0.719$0.719$0.65586,506
$0.678-0.042-5.8%$0.723$0.738$0.67862,355
$0.720+0.030+4.3%$0.693$0.720$0.67290,483
$0.690-0.022-3.1%$0.735$0.735$0.681142,117
$0.712-0.028-3.8%$0.765$0.765$0.71044,896
$0.740-0.034-4.4%$0.765$0.768$0.73124,500
$0.774+0.032+4.3%$0.754$0.780$0.74046,000
$0.742-0.012-1.6%$0.750$0.765$0.73050,700
$0.755+0.031+4.3%$0.702$0.780$0.680404,900
$0.724-0.017-2.3%$0.747$0.747$0.72295,400
$0.741-0.077-9.4%$0.839$0.849$0.734168,800
$0.818+0.045+5.9%$0.780$0.821$0.76363,100
$0.772-0.048-5.8%$0.800$0.800$0.757167,400
$0.820-0.021-2.5%$0.830$0.850$0.81056,900
$0.841+0.002+0.3%$0.830$0.869$0.82290,100
$0.839-0.022-2.5%$0.860$0.880$0.820148,800
$0.860-0.029-3.2%$0.880$0.893$0.86040,300
$0.889-0.011-1.3%$0.910$0.910$0.88052,200
$0.900-0.020-2.1%$0.900$0.918$0.89070,100
$0.920-0.026-2.8%$0.960$0.960$0.92070,900
$0.946+0.005+0.5%$0.940$0.970$0.91589,500
$0.942+0.007+0.8%$0.930$0.970$0.930208,300
$0.935-0.031-3.2%$0.930$0.980$0.88298,100
$0.965-0.045-4.4%$1.000$1.011$0.910234,800
$1.010-0.020-1.9%$1.000$1.040$0.980213,800
$1.030+0.060+6.2%$0.990$1.050$0.942321,500
$0.970-0.004-0.4%$0.948$0.990$0.920200,700
$0.974+0.034+3.6%$0.891$1.000$0.891361,200
$0.940-0.065-6.5%$0.880$0.960$0.8001,778,700
$1.005+0.039+4.0%$0.993$1.040$0.94720,008,800
$0.966+0.088+10.1%$0.889$0.966$0.874167,800
$0.878+0.055+6.8%$0.860$0.897$0.829180,000
$0.822-0.063-7.1%$0.894$0.900$0.821146,600
$0.885+0.007+0.8%$0.917$0.972$0.850118,800
$0.878-0.083-8.6%$0.951$0.973$0.856404,200
$0.961+0.010+1.1%$0.950$0.998$0.95099,700
$0.950-0.090-8.6%$1.050$1.056$0.936320,300
$1.040-0.040-3.7%$1.080$1.085$1.040109,000
$1.080-0.030-2.7%$1.100$1.120$1.070140,500
$1.110+0.050+4.7%$1.060$1.120$1.060151,200
$1.060-0.070-6.2%$1.140$1.140$1.040173,100
$1.130+0.030+2.7%$1.100$1.150$1.10094,100
$1.100-0.030-2.7%$1.110$1.130$1.090104,900
$1.130-0.010-0.9%$1.140$1.190$1.090243,200
$1.1400.0000.0%$1.170$1.180$1.115197,500
$1.140-0.050-4.2%$1.200$1.210$1.120248,900
$1.190-0.050-4.0%$1.220$1.250$1.190249,100
$1.240+0.030+2.5%$1.190$1.260$1.190171,193
$1.210-0.100-7.6%$1.290$1.290$1.190387,166
$1.310+0.030+2.3%$1.270$1.350$1.220545,100
$1.280+0.160+14.3%$1.280$1.430$1.08010,263,400

Splits

3 splits since 2020 · NASDAQ:CELZ · every price before a split is adjusted for it

DayRatioWhat
1-for-10Consolidation
1-for-500Consolidation
1-for-150Consolidation
Ticker
NASDAQ:CELZ
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
NASDAQ
Currency
USD

What changed lately

Latest news

All Creative Medical Technology Holdings, Inc. news

Creative Medical Technology Holdings, Inc. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
15 in the last 12 months · 99 in all · newest Oct 20, 2026 · oldest 2020

Where Creative Medical Technology Holdings, Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:CELZ · Home listing · This pageNASDAQUnited StatesUSD
BOATS:CELZBOATSUnited StatesUSD

Valuation

EV/sales −1,263× against a median of 5.6×: the lowest of 4 Biotechnology companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026

Enterprise value
−$3.79M USD
P/E
Loss
EV/sales
−1,263×
EV/EBITDA
Negative EBITDA
Price/book
0.4×
Gross margin
66.9%
Operating margin
Revenue too small
Net margin
Revenue too small
Debt to equity
0.0×
Beta vs S&P 500
1.53

Biotechnology: the 10 companies nearest in size, of 890 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Creative Medical Technology Holdings, Inc. · NASDAQ:CELZUS$3.06M−US$3.79Mn/a−1,263×n/a0.4×n/a0.0×1.53
Aprea Therapeutics, Inc. · NASDAQ:APREUS$3.25M−US$34.60Mn/an/an/a0.1×n/a0.0×0.73
Spago Nanomedical AB · OMXSTO:SPAGOUS$3.20MUS$22,074n/a5.6×n/a1.0×n/a0.0×n/a
Kiora Pharmaceuticals, Inc. · NASDAQ:KPRXUS$3.19M−US$12.81Mn/a−12.8×n/a0.2×n/a0.0×1.54
Azitra Inc · AMEX:AZTRUS$3.13M−US$618,677n/an/an/a0.7×n/a0.0×0.60
NuCana plc · NASDAQ:NCNAUS$3.12M−US$21.39Mn/an/an/a0.1×n/a0.0×1.58
Revive Therapeutics Ltd. · CSE:RVVUS$3.10MUS$3.14Mn/an/an/an/an/an/a0.56
Skye Bioscience, Inc. · NASDAQ:SKYEUS$3.10M−US$1.71Mn/an/an/a2.3×n/a0.0×0.85
Oncology Pharma Inc. · OTC:ONPHUS$3.04Mn/an/an/an/an/an/an/a1.62
Imunon, Inc. · NASDAQ:IMNNUS$3.00MUS$5.90Mn/an/an/a1.1×n/a2.6×0.57
Gelteq Limited · NASDAQ:GELSUS$2.89MUS$6.28Mn/a57.1×n/a0.3×n/a0.4×0.83
Median of the othersUS$3.11M−US$618,6775.6×0.5×0.0×0.83

Forecasts

1 strong buy · Analysts' consensus from EODHD, read Nov 9, 2026. Not 6ix's view and not investment advice.

Price target
20.00 USD · Analysts' mean
EPS, year to Dec 2026
-1.18 · 1 analyst

Team and board

Officers

OfficerRole
Timothy WarbingtonCEO & Co-Founder
Donald DickersonChief Financial Officer

Board

DirectorRole
Bruce S. UrdangBoard Member
Mike FingerBoard Member
Susan SnowBoard Member

Events

QuarterResultsShare move
Q3 2026Nov 6, 2026 · After close−1.6%
Q2 2026Aug 7, 2026+4.3%
Q1 2026May 8, 2026 · After close−5.6%
Q4 2025Feb 25, 2026+1.7%
Q3 2025Nov 7, 2025 · After close+8.6%
Q2 2025Aug 8, 2025 · After close−12.3%
Q1 2025May 9, 2025 · After close−7.5%
Q4 2024Mar 20, 2025 · After close+3.6%
Q3 2024Nov 8, 2024 · After close+3.2%
Q2 2024Aug 9, 2024 · After close+16.7%
All 20 quarters
QuarterResultsShare move
Q1 2024May 10, 2024 · After close−0.5%
Q4 2023Mar 22, 2024 · After close+4.4%
Q3 2023Nov 14, 2023 · After close+4.3%
Q2 2023Aug 11, 2023 · After close+0.8%
Q1 2023May 12, 2023 · After close0.0%
Q4 2022Mar 31, 2023 · After close−0.6%
Q3 2022Nov 10, 2022 · After close−1.2%
Q2 2022Aug 12, 2022 · After close−2.1%
Q1 2022May 13, 2022 · After close−8.7%
Q4 2021Mar 30, 2022 · After close+15.0%

Open Events

Financings

RaiseDate
Warrant exercise of existing warrants exercised for common stock
Announced: about US$4.5M · US$1.6 a share · Warrants at US$1.6 for 60 months · Roth Capital Partners
Dealers: Roth Capital Partners
Use of proceeds: Working capital and general corporate purposes
Jun 30, 2026
Warrant exercise of common shares on exercise of existing warrants
Announced: about US$4.2M · US$3.75 a share · Warrants at US$3.75 for 60 months · Roth Capital Partners
Dealers: Roth Capital Partners
Use of proceeds: Working capital and general corporate purposes
Oct 29, 2025
Warrant exercise of existing warrants to purchase common stock
Announced: about US$3.7M · US$4.42 a share · Warrants at US$3.75 for 60 months · Roth Capital Partners
Dealers: Roth Capital Partners
Use of proceeds: Working capital and general corporate purposes
Mar 6, 2025

Open Financings · Read by 6ix AI from the company's releases

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue6.00K11.0K9.00K88.6K87.8K164.5K165.5K124.4K4.80K0
Cost of revenue2.19K4.40K3.60K28.5K47.9K50.6K45.5K70.4K8.00K0
Gross profit3.81K6.60K5.40K60.1K39.8K113.9K120.0K54.0K-3.20K0
Research and development2.26M2.40M1.97M6.27M109.2K0096.6K260.1K85.3K
Selling, general and administrative3.76M3.24M3.56M3.94M2.96M1.16M1.22M1.05M898.5K665.0K
Operating income-6.14M-5.74M-5.62M-10.2M-3.13M-1.11M-1.13M-1.11M-1.18M-759.7K
Depreciation and amortization123.3K56.0K56.0K92.1K92.1K66.8K26.9K21.1K16.0K9.36K
EBITDA-6.02M-5.69M-5.56M-10.2M-3.03M-1.05M-1.10M-1.09M-1.16M-750.3K
Interest expense04.28M1.23M1.90M1.36M377.6K6.40K
Income before tax-6.00M-5.49M-5.29M-10.1M19.2M-36.3M-8.48M-13.7M-2.66M-766.1K
Income tax0000000000
Net income-6.00M-5.49M-5.29M-10.1M19.2M-36.3M-8.48M-13.7M-2.66M-766.1K
Earnings per share, basic-1.62-3.14-3.85-0.937.37-62.69-0.82-3.50-0.03-0.01
Earnings per share, diluted-2.52-3.71-3.76-0.935.61-62.69-0.82-3.50-0.03-0.01

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents7.21M5.94M3.47M8.32M10.7M98.0K88.6K304.1K13.7K221.9K
Short-term investments06.52M10.1M0
Receivables52.1K02.48K05.60K9.60K4.80K0
Inventory02.19K6.59K10.2K10.9K00
Current assets7.40M6.14M10.3M18.7M10.7M98.0K94.2K313.7K18.5K221.9K
Total assets7.81M6.67M10.7M19.2M11.3M717.8K530.8K477.2K203.1K322.5K
Accounts payable270.7K273.5K317.3K3.27M761.9K350.9K320.8K331.8K237.6K66.4K
Current liabilities284.9K327.6K371.4K3.32M1.05M40.5M8.60M4.47M2.44M453.9K
Long-term debt91525.0K
Total debt14.2K14.2K14.2K14.2K14.2K788.7K1.06M682.1K493.3K125.0K
Total liabilities284.9K327.6K371.4K3.32M1.05M40.5M8.60M4.47M2.44M480.3K
Shareholders' equity7.51M6.34M10.3M15.9M10.2M-39.8M-8.07M-3.99M-2.24M-157.8K
Shares outstanding3.70M1.75M1.37M1.41M6.34M1.54M22.5M6.02M114.8M105.0M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations-5.86M-5.30M-8.03M-7.80M-2.22M-434.6K-1.21M-1.05M-889.6K-445.2K
Capital spending-5-200.0K-100.0K-40-250.0K-300-10.0K
Free cash flow-5.86M-5.30M-8.13M-7.80M-2.22M-684.6K-1.21M-1.05M-889.6K-455.2K
Cash from investing-50.5K6.32M3.45M-10.1M0-250.0K0-250.0K0-10.0K
Cash from financing7.17M1.45M-271.0K15.5M12.8M693.9K997.7K1.34M681.5K677.0K
Dividends paid-4.78M
Share buybacks-10.0K-175.0K-271.0K0-196.8K0100.0K100.0K
Change in cash1.27M2.47M-4.85M-2.40M10.6M9.36K-215.4K290.4K-208.2K221.8K

Open Financials

Filings

FilingDateTypeFiled with
8-K · Current reportNov 13, 2026Current reportSEC
DEF 14A · Proxy statementNov 10, 2026Meeting noticeSEC
10-Q · Quarterly reportNov 6, 2026Quarterly reportSEC
SCHEDULE 13D · Big-stake noticeOct 1, 2026Big-stake noticeSEC
4 · Change in ownershipSep 25, 2026Insider tradeSEC
8-K · Current reportSep 25, 2026Material contractSEC
8-K · Current reportAug 31, 2026Meeting outcomeSEC
10-Q · Quarterly reportAug 7, 2026Quarterly reportSEC
424B3 · ProspectusAug 3, 2026Offer documentSEC
EFFECT · Notice that a registration is effectiveAug 3, 2026Other filingsSEC
Show 200 filings
FilingDateTypeFiled with
S-3 · Registration statementJul 24, 2026Offer documentSEC
DEF 14A · Proxy statementJul 14, 2026Meeting noticeSEC
8-K · Current reportJul 2, 2026Material contractSEC
PRE 14A · Preliminary proxy statementJul 1, 2026Meeting noticeSEC
RW · Request to withdraw a registrationJun 30, 2026Other filingsSEC
S-1/A · Registration statement, amendedJun 26, 2026Offer documentSEC
S-1 · Registration statementJun 25, 2026Offer documentSEC
DRS · Draft registration statementMay 28, 2026Offer documentSEC
10-Q · Quarterly reportMay 8, 2026Quarterly reportSEC
10-K/A · Annual report, amendedApr 24, 2026Annual reportSEC
10-K · Annual reportMar 20, 2026Annual reportSEC
8-K · Current reportDec 31, 2025Meeting outcomeSEC
8-K · Current reportDec 19, 2025Meeting outcomeSEC
424B3 · ProspectusDec 16, 2025Offer documentSEC
EFFECT · Notice that a registration is effectiveDec 15, 2025Other filingsSEC
CORRESP · Letter to the SECDec 9, 2025Other filingsSEC
S-3 · Registration statementNov 21, 2025Offer documentSEC
DEF 14A · Proxy statementNov 13, 2025Meeting noticeSEC
8-K · Current reportNov 12, 2025Management or board changeSEC
10-Q · Quarterly reportNov 7, 2025Quarterly reportSEC
PRE 14A · Preliminary proxy statementNov 3, 2025Meeting noticeSEC
8-K · Current reportOct 31, 2025Material contractSEC
DEF 14A · Proxy statementOct 30, 2025Meeting noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedAug 14, 2025Big-stake noticeSEC
10-Q · Quarterly reportAug 8, 2025Quarterly reportSEC
SCHEDULE 13G · Big-stake noticeMay 15, 2025Big-stake noticeSEC
10-Q · Quarterly reportMay 9, 2025Quarterly reportSEC
8-K · Current reportMay 6, 2025Meeting outcomeSEC
10-K/A · Annual report, amendedApr 25, 2025Annual reportSEC
424B3 · ProspectusApr 15, 2025Offer documentSEC
EFFECT · Notice that a registration is effectiveApr 14, 2025Other filingsSEC
8-K · Current reportApr 11, 2025Current reportSEC
CORRESP · Letter to the SECApr 9, 2025Other filingsSEC
UPLOAD · Letter from the SECApr 8, 2025Other filingsSEC
10-K/A · Annual report, amendedApr 4, 2025Annual reportSEC
S-3 · Registration statementApr 2, 2025Offer documentSEC
10-K/A · Annual report, amendedMar 19, 2025Annual reportSEC
DEF 14A · Proxy statementMar 17, 2025Meeting noticeSEC
8-K · Current reportMar 14, 2025Management or board changeSEC
10-K · Annual reportMar 14, 2025Annual reportSEC
PRE 14A · Preliminary proxy statementMar 7, 2025Meeting noticeSEC
8-K · Current reportMar 7, 2025Material contractSEC
4 · Change in ownershipFeb 20, 2025Insider tradeSEC
8-K · Current reportDec 26, 2024Meeting outcomeSEC
424B3 · ProspectusNov 20, 2024Offer documentSEC
EFFECT · Notice that a registration is effectiveNov 20, 2024Other filingsSEC
CORRESP · Letter to the SECNov 15, 2024Other filingsSEC
UPLOAD · Letter from the SECNov 14, 2024Other filingsSEC
10-Q · Quarterly reportNov 8, 2024Quarterly reportSEC
S-1 · Registration statementNov 8, 2024Offer documentSEC
DEF 14A · Proxy statementNov 4, 2024Meeting noticeSEC
PRER14AOct 23, 2024Other filingsSEC
8-K · Current reportOct 23, 2024Material contractSEC
424B5 · ProspectusOct 23, 2024Offer documentSEC
EFFECT · Notice that a registration is effectiveOct 16, 2024Other filingsSEC
CORRESP · Letter to the SECOct 10, 2024Other filingsSEC
UPLOAD · Letter from the SECOct 10, 2024Other filingsSEC
PRE 14A · Preliminary proxy statementOct 4, 2024Meeting noticeSEC
S-3 · Registration statementOct 4, 2024Offer documentSEC
10-Q · Quarterly reportAug 9, 2024Quarterly reportSEC
8-K · Current reportJul 25, 2024Meeting outcomeSEC
DEF 14A · Proxy statementJun 5, 2024Meeting noticeSEC
8-K · Current reportMay 17, 2024Material contractSEC
PRE 14A · Preliminary proxy statementMay 17, 2024Meeting noticeSEC
10-Q · Quarterly reportMay 10, 2024Quarterly reportSEC
10-K/A · Annual report, amendedApr 29, 2024Annual reportSEC
10-K · Annual reportMar 22, 2024Annual reportSEC
8-K · Current reportDec 20, 2023Meeting outcomeSEC
10-Q · Quarterly reportNov 14, 2023Quarterly reportSEC
DEF 14A · Proxy statementNov 3, 2023Meeting noticeSEC
10-Q · Quarterly reportAug 11, 2023Quarterly reportSEC
4 · Change in ownershipJun 29, 2023Insider tradeSEC
8-K · Current reportJun 28, 2023Current reportSEC
8-K · Current reportJun 9, 2023Current reportSEC
SC 13G/A · Big-stake notice, amendedMay 26, 2023Big-stake noticeSEC
10-Q · Quarterly reportMay 12, 2023Quarterly reportSEC
SC 13G · Big-stake noticeMay 1, 2023Big-stake noticeSEC
10-K/A · Annual report, amendedMay 1, 2023Annual reportSEC
10-K · Annual reportMar 31, 2023Annual reportSEC
8-K · Current reportDec 19, 2022Meeting outcomeSEC
4 · Change in ownershipNov 23, 2022Insider tradeSEC
10-Q · Quarterly reportNov 10, 2022Quarterly reportSEC
DEF 14A · Proxy statementOct 26, 2022Meeting noticeSEC
4 · Change in ownershipSep 29, 2022Insider tradeSEC
4 · Change in ownershipSep 28, 2022Insider tradeSEC
4 · Change in ownershipSep 22, 2022Insider tradeSEC
10-Q · Quarterly reportAug 12, 2022Quarterly reportSEC
8-K · Current reportJul 14, 2022Current reportSEC
4 · Change in ownershipJun 14, 2022Insider tradeSEC
4 · Change in ownershipJun 7, 2022Insider tradeSEC
4 · Change in ownershipMay 20, 2022Insider tradeSEC
424B3 · ProspectusMay 20, 2022Offer documentSEC
EFFECT · Notice that a registration is effectiveMay 20, 2022Other filingsSEC
CORRESP · Letter to the SECMay 17, 2022Other filingsSEC
UPLOAD · Letter from the SECMay 16, 2022Other filingsSEC
10-Q · Quarterly reportMay 13, 2022Quarterly reportSEC
S-3 · Registration statementMay 10, 2022Offer documentSEC
DMay 5, 2022Other filingsSEC
RW · Request to withdraw a registrationMay 4, 2022Other filingsSEC
8-K · Current reportMay 4, 2022Material contractSEC
8-K · Current reportMay 4, 2022Material contractSEC
10-K/A · Annual report, amendedApr 29, 2022Annual reportSEC
S-1 · Registration statementApr 22, 2022Offer documentSEC
10-K · Annual reportMar 30, 2022Annual reportSEC
SC 13G/A · Big-stake notice, amendedFeb 14, 2022Big-stake noticeSEC
SC 13G/A · Big-stake notice, amendedFeb 11, 2022Big-stake noticeSEC
SC 13G/A · Big-stake notice, amendedFeb 11, 2022Big-stake noticeSEC
4 · Change in ownershipFeb 11, 2022Insider tradeSEC
4 · Change in ownershipFeb 11, 2022Insider tradeSEC
8-K · Current reportFeb 11, 2022Management or board changeSEC
3 · Initial statement of ownershipJan 5, 2022Insider tradeSEC
SC 13G · Big-stake noticeDec 17, 2021Big-stake noticeSEC
3 · Initial statement of ownershipDec 13, 2021Insider tradeSEC
3 · Initial statement of ownershipDec 13, 2021Insider tradeSEC
SC 13G · Big-stake noticeDec 10, 2021Big-stake noticeSEC
SC 13G · Big-stake noticeDec 8, 2021Big-stake noticeSEC
8-K · Current reportDec 7, 2021Material contractSEC
424B4 · ProspectusDec 6, 2021Offer documentSEC
EFFECT · Notice that a registration is effectiveDec 3, 2021Other filingsSEC
CERT · Exchange's certificate of listingDec 2, 2021Other filingsSEC
8-A12B · Registration of shares for listing on an exchangeDec 2, 2021Other filingsSEC
CORRESP · Letter to the SECDec 2, 2021Other filingsSEC
S-1/A · Registration statement, amendedDec 2, 2021Offer documentSEC
UPLOAD · Letter from the SECDec 2, 2021Other filingsSEC
S-1/A · Registration statement, amendedDec 1, 2021Offer documentSEC
CORRESP · Letter to the SECNov 30, 2021Other filingsSEC
CORRESP · Letter to the SECNov 30, 2021Other filingsSEC
CORRESP · Letter to the SECNov 23, 2021Other filingsSEC
S-1/A · Registration statement, amendedNov 23, 2021Offer documentSEC
10-Q · Quarterly reportNov 15, 2021Quarterly reportSEC
8-K · Current reportNov 9, 2021Current reportSEC
8-K · Current reportNov 5, 2021Current reportSEC
UPLOAD · Letter from the SECOct 7, 2021Other filingsSEC
S-1 · Registration statementSep 27, 2021Offer documentSEC
DEF 14CSep 24, 2021Meeting noticeSEC
8-K · Current reportSep 22, 2021Management or board changeSEC
PRE 14CSep 7, 2021Meeting noticeSEC
DAug 27, 2021Other filingsSEC
10-Q · Quarterly reportAug 16, 2021Quarterly reportSEC
8-K · Current reportAug 12, 2021Material contractSEC
4 · Change in ownershipJul 22, 2021Insider tradeSEC
4 · Change in ownershipJul 16, 2021Insider tradeSEC
4 · Change in ownershipJul 16, 2021Insider tradeSEC
4 · Change in ownershipJul 16, 2021Insider tradeSEC
4 · Change in ownershipJun 29, 2021Insider tradeSEC
10-Q · Quarterly reportMay 17, 2021Quarterly reportSEC
8-K · Current reportApr 2, 2021Material contractSEC
8-K · Current reportMar 25, 2021Current reportSEC
10-K · Annual reportMar 17, 2021Annual reportSEC
8-K · Current reportMar 12, 2021Current reportSEC
8-K · Current reportMar 5, 2021Current reportSEC
8-K · Current reportFeb 22, 2021Current reportSEC
8-K/A · Current report, amendedFeb 22, 2021Material contractSEC
8-K · Current reportFeb 18, 2021Material contractSEC
8-K · Current reportFeb 12, 2021Current reportSEC
8-K · Current reportFeb 8, 2021Current reportSEC
8-K · Current reportJan 14, 2021Current reportSEC
4 · Change in ownershipJan 8, 2021Insider tradeSEC
4 · Change in ownershipJan 8, 2021Insider tradeSEC
8-K · Current reportJan 4, 2021Current reportSEC
4 · Change in ownershipDec 31, 2020Insider tradeSEC
4 · Change in ownershipDec 31, 2020Insider tradeSEC
4 · Change in ownershipDec 31, 2020Insider tradeSEC
10-Q · Quarterly reportNov 13, 2020Quarterly reportSEC
4 · Change in ownershipOct 2, 2020Insider tradeSEC
4 · Change in ownershipOct 2, 2020Insider tradeSEC
10-Q · Quarterly reportAug 14, 2020Quarterly reportSEC
4 · Change in ownershipJun 5, 2020Insider tradeSEC
4 · Change in ownershipJun 5, 2020Insider tradeSEC
10-Q · Quarterly reportMay 15, 2020Quarterly reportSEC
10-K · Annual reportApr 6, 2020Annual reportSEC
NT 10-K · Late filing noticeMar 30, 2020Explanation requestSEC
8-K · Current reportMar 24, 2020Current reportSEC
4 · Change in ownershipFeb 19, 2020Insider tradeSEC
4 · Change in ownershipFeb 19, 2020Insider tradeSEC
8-K · Current reportJan 31, 2020Current reportSEC
DEFR14CJan 3, 2020Other filingsSEC
4 · Change in ownershipDec 13, 2019Insider tradeSEC
4 · Change in ownershipDec 13, 2019Insider tradeSEC
4 · Change in ownershipDec 13, 2019Insider tradeSEC
DEF 14CNov 22, 2019Meeting noticeSEC
10-Q · Quarterly reportNov 14, 2019Quarterly reportSEC
4 · Change in ownershipNov 5, 2019Insider tradeSEC
PRE 14CNov 5, 2019Meeting noticeSEC
8-K · Current reportOct 16, 2019Material contractSEC
DEF 14CSep 13, 2019Meeting noticeSEC
8-K · Current reportSep 9, 2019Current reportSEC
PRE 14CAug 30, 2019Meeting noticeSEC
10-Q · Quarterly reportAug 13, 2019Quarterly reportSEC
8-K · Current reportJul 31, 2019Material contractSEC

This page holds 200 of 412 filings. Open Filings

Open Filings · All of its filings on SEC EDGAR

Cap table

Built by 6ix from Creative Medical Technology Holdings, Inc.’s releases · as of Nov 6, 2026

Common shares
7,597,557
Fully diluted
7,597,557

Fully diluted

LineSharesAs of
Common shares7,597,557Nov 6, 2026

Share count over time

CountShares
Nov 6, 20267,597,557

Open Cap table

Shareholders

Institutions

HolderSharesOf the companyValueChange vs Jun 30Filed
MYDA Advisors LLC4.5M59.2%US$4.21MNewNov 13, 2026
Virtu Financial LLC84,4951.1%US$79,000NewNov 17, 2026
Vanguard82,8221.1%US$77,438+56,954Nov 13, 2026
Acadian Asset Management LLC81,2931.1%US$74,000NewNov 9, 2026
Citadel26,2950.35%US$24,575NewNov 16, 2026
Geode Capital25,6990.34%US$24,025−100Nov 6, 2026
Hrt Financial LP19,9180.26%US$18,000NewNov 13, 2026
StoneX Group Inc.15,2660.20%US$10,137NewNov 3, 2026
Global Retirement Partners, LLC8,6180.11%US$8,054+4,500Nov 10, 2026
UBS5,2010.07%US$4,863+3,140Nov 10, 2026
All 15 holders
HolderSharesOf the companyValueChange vs Jun 30Filed
Tower Research Capital LLC (TRC)4,0620.05%US$3,796−791Nov 16, 2026
Morgan Stanley264<0.01%US$247−250Nov 13, 2026
Berthel, Fisher & Company Financial Services, Inc.50<0.01%US$47NewNov 13, 2026
SBI Securities Co., Ltd.1<0.01%US$1−42Oct 21, 2026
Caitong International Asset Management Co., Ltd1<0.01%US$1NewOct 29, 2026

Funds

HolderSharesOf the companyValueChangeAs of
Fidelity Extended Market Index Fund27,5490.36%US$61,985+9,220May 31, 2026
Vanguard Extended Market Index Fund20,3500.27%US$29,508No changeJun 30, 2026
Fidelity Series Total Market Index Fund3,9690.05%US$8,930No changeMay 31, 2026
Fidelity Total Market Index Fund1,5510.02%US$3,490No changeMay 31, 2026

Big stakes

HolderStakeSharesDate
Timothy Warbington13.70%1.04MSep 24, 2026

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Susan Snow
Other companies: NeoVolta Inc. (Director · Since at least Jul 27, 2022); Basin Water Inc (Director · May 6, 2008 – May 6, 2008 · Past)
Board Member · Since at least Dec 2, 2021
Thomas Ichim
Other companies: Therapeutic Solutions International, Inc. (Director · Oct 18, 2016 – Oct 1, 2024 · Past)
Director · May 18, 2016 – Jul 20, 2021 · Past
Amit Nilkanth PatelDirector · May 18, 2016 – Jul 15, 2021 · Past
Bruce S. UrdangBoard Member · Since at least Dec 2, 2021
Courtney BartlettDirector of Clinical Development · Feb 20, 2025 – Nov 4, 2026 · Past
Donald DickersonChief Financial Officer · Since at least May 18, 2016
Mike FingerBoard Member · Since at least Dec 2, 2021
Steven L WhitePresident, Director · Jan 20, 2009 – May 18, 2016 · Past
Timothy WarbingtonCEO & Co-Founder · Since at least May 18, 2016

Open People

Log in to ask 6ix AI your own questions about Creative Medical Technology Holdings, Inc.